# TR2PATH
Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC 

[Usage Manual](https://github.com/mitrofanova-lab/TR2PATH/blob/main/TR2PATH_Installation_and_demo_manual.pdf)
